Kieran F Scott Selected Research

Kieran F Scott Research Topics

Disease

10	Neoplasms (Cancer) 03/2022 - 10/2004
8	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 10/2004
8	Inflammation (Inflammations) 11/2021 - 01/2005
6	Rheumatoid Arthritis 10/2021 - 01/2003
3	Asthma (Bronchial Asthma) 04/2010 - 01/2003
2	Infections 11/2021 - 01/2008
2	Carcinogenesis 04/2021 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 04/2021 - 01/2021
2	Atherosclerosis 06/2013 - 04/2010
2	Neoplasm Metastasis (Metastasis) 08/2006 - 10/2004
2	Chronic Renal Insufficiency 01/2005 - 01/2003
2	Hypersensitivity (Allergy) 01/2005 - 01/2003
2	Urticaria (Hives) 01/2005 - 01/2003
1	Colonic Neoplasms (Colon Cancer) 04/2022
1	Glioma (Gliomas) 04/2021
1	Brain Neoplasms (Brain Tumor) 04/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Frailty 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Circulating Neoplastic Cells 01/2020
1	Disease Progression 01/2020
1	Gout 06/2013
1	Rheumatic Diseases (Rheumatism) 06/2013
1	Necrosis 01/2012
1	Confusion (Bewilderment) 01/2012
1	Cystic Fibrosis (Mucoviscidosis) 04/2010

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 03/2022 - 11/2010
6	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2013 - 01/2003
5	EnzymesIBA 11/2021 - 10/2004
5	AndrogensIBA 01/2020 - 10/2004
4	Arachidonic Acid (Vitamin F)IBA 01/2017 - 10/2004
4	Phospholipases (Phospholipase)IBA 01/2011 - 10/2004
3	Secretory Phospholipases A2IBA 11/2021 - 10/2004
3	EicosanoidsIBA 01/2021 - 10/2004
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2020
2	Hypochlorous Acid (Hypochlorite)IBA 10/2021 - 06/2013
2	SalicylatesIBA 10/2021 - 01/2003
2	CytokinesIBA 01/2012 - 01/2011
2	Phospholipases A2 (Phospholipase A2)IBA 06/2010 - 08/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2006 - 10/2004
2	Lipoxygenase (Lipoxygenase-1)IBA 08/2006 - 10/2004
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2005 - 01/2003
1	Cisplatin (Platino)FDA LinkGeneric 04/2022
1	Immune Checkpoint InhibitorsIBA 03/2022
1	Pharmaceutical PreparationsIBA 11/2021
1	Peroxidase (Myeloperoxidase)IBA 10/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	Group II Phospholipases A2IBA 01/2017
1	hypobromous acidIBA 06/2013
1	Lipase (Acid Lipase)FDA Link 05/2013
1	VimentinIBA 05/2013
1	Biological ProductsIBA 01/2012
1	LipidsIBA 06/2010
1	Oxidants (Oxidizing Agents)IBA 04/2010
1	Heparitin Sulfate (Heparan Sulfate)IBA 04/2010
1	Hormones (Hormone)IBA 12/2008
1	Small Interfering RNA (siRNA)IBA 12/2008
1	Group IV Phospholipases A2IBA 12/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2008
1	Annexin A1IBA 08/2006

Therapy/Procedure

4	Therapeutics 04/2021 - 10/2004
1	Immunotherapy 03/2022
1	Oral Surgery (Maxillofacial Surgery) 01/2005
1	Aftercare (After-Treatment) 10/2004